Cetuximab or Nimotuzumab Versus Cisplatin Concurrent with Radiotherapy for Local-Regionally Advanced Nasopharyngeal Carcinoma: a Meta-analysis

BACKGROUND: It is unclear whether Cetuximab (CTX) or Nimotuzumab (NTZ) concurrent with radiotherapy delivers equivalent or improved results with fewer toxicities over standard cisplatin (CDDP) concurrent with radiotherapy in locally advanced nasopharyngeal carcinoma (NPC). METHODS: The strategy invo...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Asian Pac J Cancer Prev
Main Authors: Liang, Zhong Guo, Lin, Guo Xiang, Ye, Jia Xiang, Li, Ye, Li, Ling, Qu, Song, Liang, Xia, Zhu, Xiao Dong
Format: Artigo
Jezik:Inglês
Izdano: West Asia Organization for Cancer Prevention 2018
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6031838/
https://ncbi.nlm.nih.gov/pubmed/29802706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2018.19.5.1397
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki